IP Library Granted Patent US 10,179,095
Granted Patent B2
US 10,179,095 · App. 16/002,092 · Granted Jan 15, 2019

Autophage activating resveratrol topical composition for skin improvement and treatment

Inventors: Byeong Deog Park (Bethlehem, PA); Chae Hyeong Park (Bethlehem, PA)
Assignee: DR. RAYMOND LABORATORIES
A61K8/062A61K8/347A61K8/361A61K8/42A61K8/63A61K9/0014A61K9/107A61K31/05A61K31/164A61K31/20A61K31/57A61K31/575A61Q19/005A61Q19/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,179,095
App. No.
16/002,092
Granted
Jan 15, 2019
Kind
B2
Abstract

An autophage activating resveratrol topical composition includes a ceramide or a pseudoceramide, a fatty acid, a phytosterol, and a resveratrol. The ceramide or pseudoceramide, the fatty acid, the phytosterol, and the resveratrol form a multi-layered encapsulation system. A method of inducing autophagy in skin includes applying the autophage activating resveratrol topical composition to a skin, and inducing autophagy in the skin to improve skin barrier function and skin self-purification function.

Claims (20)

1. An autophage activating resveratrol topical composition comprising:

0.5-1.0 wt % of a pseudoceramide,

1.0-7.0 wt % of a fatty acid,

0.01-1.0 wt % of a phytosterol, and

0.01-1.0 wt % of a resveratrol,

wherein the ceramide or pseudoceramide, the fatty acid, the phytosterol, and the resveratrol form a multi-layered encapsulation system, and

wherein the pseudoceramide is ceramide 9S, ceramide 5P, or ceramide IIIB.

2. The autophage activating resveratrol topical composition of claim 1 , wherein the fatty acid is a saturated or unsaturated carboxylic acid with a long aliphatic chain.

3. The autophage activating resveratrol topical composition of claim 1 , wherein the phytosterol is selected from the group consisting of β-sitosterol, campesterol, cholesterol, stigmasterol, stigmastanol, campestanol, brassicasterol, ergosterol, lupeol, and cycloartenol.

4. The autophage activating resveratrol topical composition of claim 1 , wherein the resveratrol is represented by the following structure:

5. The autophage activating resveratrol topical composition of claim 1 , wherein the pseudoceramide is in an amount of less than 20% of a total weight of the resveratrol topical composition.

6. The autophage activating resveratrol topical composition of claim 1 , wherein the fatty acid is in an amount of less than 70% of the total weight of the resveratrol topical composition.

7. The autophage activating resveratrol topical composition of claim 1 , wherein a weight ratio of the phytosterol and the resveratrol is between 1:9 to 9:1.

8. The autophage activating resveratrol topical composition of claim 7 , wherein the weight ratio of the phytosterol and the resveratrol is 1:1.

9. The autophage activating resveratrol topical composition of claim 1 further comprising:

emulsifier oils and cosmetic ingredients.

10. A method of inducing autophagy in skin comprising:

applying the autophage activating resveratrol topical composition of claim 1 to a skin, and

inducing autophagy in the skin to improve skin barrier function and skin self-purification function.

11. The method of claim 10 , wherein the skin is a sensitive skin or atopic dermatitis skin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2018
From: PARK, BYEONG DEOG; PARK, CHAE HYEONG
To: DR. RAYMOND LABORATORIES
Reel/Frame 046011/0382 →
Continuity (2)
Provisional Application 62516135 · Jun 7, 2017
Related Publication 20180353397A1 · Dec 13, 2018